BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32141703)

  • 21. Steatohepatitis develops rapidly in transgenic mice overexpressing Abcb11 and fed a methionine-choline-deficient diet.
    Sundaram SS; Whitington PF; Green RM
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1321-7. PubMed ID: 15650132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis.
    Behari J; Yeh TH; Krauland L; Otruba W; Cieply B; Hauth B; Apte U; Wu T; Evans R; Monga SP
    Am J Pathol; 2010 Feb; 176(2):744-53. PubMed ID: 20019186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.
    Liu H; Pathak P; Boehme S; Chiang JL
    J Lipid Res; 2016 Oct; 57(10):1831-1844. PubMed ID: 27534992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.
    Fisher FM; Chui PC; Nasser IA; Popov Y; Cunniff JC; Lundasen T; Kharitonenkov A; Schuppan D; Flier JS; Maratos-Flier E
    Gastroenterology; 2014 Nov; 147(5):1073-83.e6. PubMed ID: 25083607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
    Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. iPla2β Deficiency Suppresses Hepatic ER UPR, Fxr, and Phospholipids in Mice Fed with MCD Diet, Resulting in Exacerbated Hepatic Bile Acids and Biliary Cell Proliferation.
    Ming Y; Zhu X; Tuma-Kellner S; Ganzha A; Liebisch G; Gan-Schreier H; Chamulitrat W
    Cells; 2019 Aug; 8(8):. PubMed ID: 31409057
    [No Abstract]   [Full Text] [Related]  

  • 27. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
    JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.
    Chen Y; Song X; Valanejad L; Vasilenko A; More V; Qiu X; Chen W; Lai Y; Slitt A; Stoner M; Yan B; Deng R
    Hepatology; 2013 Apr; 57(4):1530-41. PubMed ID: 23213087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
    Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
    Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-/-) mice.
    Hrycay E; Forrest D; Liu L; Wang R; Tai J; Deo A; Ling V; Bandiera S
    Mol Cell Biochem; 2014 Apr; 389(1-2):119-32. PubMed ID: 24399466
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Zhang YH; Ma Q; Ding P; Li J; Chen LL; Ao KJ; Tian YY
    Yonsei Med J; 2018 Nov; 59(9):1064-1071. PubMed ID: 30328321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.
    Sheng L; Jena PK; Liu HX; Kalanetra KM; Gonzalez FJ; French SW; Krishnan VV; Mills DA; Wan YY
    Sci Rep; 2017 May; 7(1):1748. PubMed ID: 28496104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.
    Cheng Y; Freeden C; Zhang Y; Abraham P; Shen H; Wescott D; Humphreys WG; Gan J; Lai Y
    Biopharm Drug Dispos; 2016 Jul; 37(5):276-86. PubMed ID: 27059119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2
    Fuchs CD; Dixon ED; Hendrikx T; Mlitz V; Wahlström A; Ståhlman M; Scharnagl H; Stojakovic T; Binder CJ; Marschall HU; Trauner M
    Hepatol Commun; 2022 Sep; 6(9):2368-2378. PubMed ID: 35691019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organic anion-transporting polypeptide 1a4 (Oatp1a4) is important for secondary bile acid metabolism.
    Zhang Y; Csanaky IL; Selwyn FP; Lehman-McKeeman LD; Klaassen CD
    Biochem Pharmacol; 2013 Aug; 86(3):437-45. PubMed ID: 23747753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice.
    Wagner M; Fickert P; Zollner G; Fuchsbichler A; Silbert D; Tsybrovskyy O; Zatloukal K; Guo GL; Schuetz JD; Gonzalez FJ; Marschall HU; Denk H; Trauner M
    Gastroenterology; 2003 Sep; 125(3):825-38. PubMed ID: 12949728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.
    Kim YC; Jung H; Seok S; Zhang Y; Ma J; Li T; Kemper B; Kemper JK
    Hepatology; 2020 Jun; 71(6):2118-2134. PubMed ID: 31549733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    Zhang S; Wang J; Liu Q; Harnish DC
    J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.